Tenascin-C expression in normal, inflamed, and scarred human corneas

British Journal of Ophthalmology

Volumn 81, Issue 8, 1997, Pages 677-682

  Maseruka, H ^a,b   Bonshek, R E ^a,b   Tullo, A B ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER ROYAL EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TENASCIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA INJURY; CORNEA NEOVASCULARIZATION; CORNEA ULCER; HERPES SIMPLEX KERATITIS; HERPES ZOSTER OPHTHALMICUS; HUMAN; HUMAN TISSUE; KERATITIS; PENETRATING KERATOPLASTY; PRESCHOOL CHILD; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; ROSACEA; SCHOOL CHILD;

EID: 0030953371     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.81.8.677     Document Type: Article

References (41)

1. Siri A, Carnemolla B, Saginati M, Leprini A, Casari G, Baralle F, et al. Human tenascin: primary structure, premRNA splicing patterns and localisation of the epitopes recognised by two monoclonal antibodies. Nucleic Acids Res 1991;19:525-31.
2. Grumet M, Hoffman S, Crossin KL, Eldelman GM. Cytotactin, an extracellular matrix protein of neural and non-neural tissues that mediates glia-neuron interaction. Proc Natl Acad Sci 1985;82:8075-9.
3. Bourdon MA, Wikstrand CJ, Furthmaryr H, Matthews TJ, Bigner DD. Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody. Cancer Res 1983;43:2796-805.
4. Chiquet M, Fambrough DM. Chick myotendinous antigen II. A novel extracellular matrix glycoprotein complex consisting of large disulphide-linked subunits. J Cell Biol 1984; 98:1937-46.
5. Erickson HP, Inglesias JL. A six-armed oligomer isolated from cell surface fibronectin preparations. Nature 1984; 311:267-9.
6. Kruse J, Keilhauer G, Faissner A, Timpl R, Schachner M. The J1 glycoprotein-a novel nervous system cell adhesion molecule of the L2/HNK-1 family. Nature 1985;316:146-8.
7. Chiquet-Ehrismann R, Hagios C, Matsumoto K. The tenascin gene family. Perspect Develop Neurobiol 1994;2:3-7.
8. Chiquet-Ehrismann R, Mackie J, Pearson C, Sakakura T. Tenascin: an extracellular matrix protein involved in tissue interactions during foetal development and oncogenesis. Cell 1986;47:131-9.
9. End P, Panayotou G, Entwistle A, Waterfield MD, Chiquet M. Tenascin: a modulator of cell growth. Eur J Biochem 1992;209:1041-51.
10. Crossin KL. Cytotactin binding: inhibition of stimulated proliferation and intracellular alkalinisation in fibroblasts. Proc Natl Acad Sci 1991;88:11403-7.
11. Joshi P, Chung C-Y, Aukhil I, Erickson HP. Endothelial cells adhere to the RGD domain and the fibrinogen-like terminal knob of tenascin. J Cell Sci 1993;106:389-400.
12. Spring J, Beck K, Chiquet-Eherismann R. Two contrary functions of tenascin: dissection of the active sites by recombinant tenascin fragments. Cell 1989;59:325-34.
13. Chiquet-Eherismann R. Anti-adhesive molecules of the extracellular matrix. Curr Opin Cell Biol Chem 1991;3:800-4.
14. Erickson HP, Bourdon MA. Tenascin: an extracellular matrix protein prominent in specialised embryonic tissues and tumours. Annu Rev Cell Biol 1989;5:71-92.
15. r 220,000 isoform expression correlates with corneal migration. Development 1991;112:605-14.
16. Sakakura T, Kusano I. Tenascin in tissue perturbation. Acta Pathol Jpn 1991;41:247-58.
17. Tervo T, van Setten GB, Lehto I, Tervo K, Tarkkanen A, Virtanen I. Immuno-histochemical demonstration of tenascin in the normal human limbus with special reference to trabeculectomy. Ophthalmic Res 1990;22:128-33.
18. Uusitalo M. Immunohistochemical localisation of chondroitin sulphate proteoglycan and tenascin in the human eye compared with HNK-1 epitope. Graefes Arch Clin Exp Ophthalmol 1994;232:657-65.
19. Latvala T, Tervo K, Mustonen R, Tervo T. Expression of cellular fibronectin and tenascin in the rabbit cornea after excimer laser photorefractive keratectomy: a 12 month study. Br J Ophthalmol 1995;79:65-9.
20. Tervo K, van Setten GB, Beuerman RW, Virtanen I, Tarkkanen A, Tervo T. Expression of tenascin and cellular fibronectin in the rabbit cornea after anterior keratectomy. Immunohistochemical study of wound healing dynamics. Invest Ophthalmol Vis Sci 1991;32:2912-8
21. Van Setten GB, Koch JW, Tervo K, Lang GK, Tervo T, Naumann GO, et al. Expression of tenascin and fibronectin in the rabbit cornea after excimer laser surgery. Graefes Arch Clin Exp Ophthalmol 1992;230:178-83.
22. Betz P, Nerlich A, Tubell J, Penning R, Eisenmenger W. Localisation of tenascin in human skin wounds - an immunohistochemical study. Int J Leg Med 1993;105:325-8.
23. Mackie EJ, Halfter W, Liverani D. Induction of tenascin in healing wounds. J Cell Biol 1988;107:2757-67.
24. Wallace WAH, Howie SEM, Lamb D, Salter DM. Tenascin immunoreactivity in cryptogenic fibrosing alveolitis. J Pathol 1995;175:415-20.
25. Balza E, Siri A, Ponassi M, Caocci F, Linnala A, Virtanen I, et al. Production and characterization of monoclonal antibodies specific for different epitopes of human tenascin. FEBS Lett 1993;332:39-43.
26. Tremble P, Chiquet-Ehrismann R, Werb Z. The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts. Mol Biol Cell 1994;5:439-53.
27. Ruegg CR, Chiquet-Ehrismann R, Alkan SS. Tenascin, an extracellular matrix protein, exerts immunomodulatory activities. Proc Natl Acad Sci 1989;86:7437-41.
28. Hemasath TJ, Marton LS, Stefansson K. Inhibition of T cell activation by the extracellular matrix protein tenascin. J Immunol 1994;152:4199-5207.
29. Zagzag D, Friedlander DR, Dosik J, Chikramane S, Chan W, Greco MA, et al. Tenascin-C expression by angiogenic vessels in human astrocytomas and by human brain endothelial cells in vitro. Cancer Res 1996;56:182-9.
30. Zagzag D, Friedlander DR, Miller DC, Dosik J, Cangiarella J, Kostianovsky M, et al. Tenascin expression in astrocytomas correlates with angiogenesis. Cancer Res 1995;55:907-14.
31. 3 integrins. J Cell Sci 1993;105:1001-12.
32. Canfield AE, Schor AM. Evidence that tenascin and thrombospondin-1 modulate sprouting of endothelial cells. J Cell Sci 1995;108:797-809.
33. Schenk S, Bruckner-Tuderman L, Chiquet-Eherismann R. Dermo-epidermal separation is associated with induced tenascin expression in human skin. Br J Dermatol 1995;133:13-22.
34. Saga Y, Yagi T, Ikawa Y, Sakakura T, Aizawa S. Mice develop normally without tenascin. Genes Dev 1992;6: 1821-31.
35. Brookfield J. Can genes be truly redundant? Curr Biol 1992; 2:553-4.
36. Braun T, Rudnicki MA, Arnold H-H, Jaenisch R. Targeted inactivation of the muscle regulatory gene Myf-5 results in abnormal rib development and perinatal death. Cell 1992; 71:369-82.
37. Joyner AL, Herrup K, Auerbach BA, Davis CA, Rossant J. Subtle cerebellar phenotype in mice homozygous for a targeted deletion of the En-2 homeobox. Science 1991;251: 1239-43.
38. Rudnicki MA, Braun T, Hinuma S, Jaenisch R. Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development. Cell 1992;71:383-90.
39. Rothe J, Lesslauer W, Lotscher H, Lang Y, Koebel P, Kontgen F, et al. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 1993; 364:798-802.
40. Hooper C. Genetic knockouts: surprises, lessons, dreams. JNIH Res 1992;4:34-5.
41. Smithies O. Animal models of human genetic diseases. TIG 1992;9:112-6.